We are monitoring the impact of COVID-19 on Aptamers Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 1071
Share on
Share on

Global Aptamers Market Analysis – By Type (Peptide Aptamers (DNA-Based Aptamers, RNA-Based Aptamers, XNA-Based Aptamers),Nucleic Acid Aptamers), Application (Therapeutics Development, Diagnostics, Research and Development), End User (Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres), Region - Industry Size, Share, Trends, Forecast, Growth | 2019 - 2024

Pulished: August, 2019
ID: 1071
Pages: 175

Global Aptamers Market Size & Growth (2019 - 2024)

The market size for Aptamers at a global level was worth USD 207.7 million in 2019 and estimated to reach USD 448.8 million by the end of 2024 with a growing potential of 16.66 % during the forecast period 2019-2024.

Aptamers are oligonucleotides that bind to a target protein, lipid, or nucleic acid molecules with high specificity. Aptamers are generated quickly and applied in the inhibition, characterization of proteins and for specific detection. Aptamers can be used as pharmaceutical leads, functional proteomic levels with antibodies, detection reagents, and small molecules. Aptamers can be engineered to have higher specificity and affinity for a number of targets.

The enormous opportunities offered by the market for the key players are drug discovery, biomarker discovery, and diagnostics segments. The launch of Macugen, the first aptamer drug and the first diagnostic test for testing mycotoxins in grains has recognized the potential of aptamers in diagnostics and therapeutics. So, the global market for aptamers is expected to grow, backed by technological advancements with respect to selection processes and synthesis.

The major factor driving the growth of the market are technological advancements, increasing R&D investments in pharmaceutical and biotechnology industries, low cost and high efficacy in binding to large molecules compared to antibodies and the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX) will boost this market positively.

Stringent regulations in the use of aptamers, Ethical issues of the aptamers that are obtained from the animals, slow in reaching the market place owing to regulatory hurdles are hindering the growth of the market.

Due to the increasing adoptions of aptamers in chemical and food industries which are expected to provide growth opportunities for the stakeholders involved in the market. Growing demand among the public for the aptamers due to benefits associated with it such as their high efficiency and low cost compared to antibodies are the factors that are expected to provide lucrative growth opportunities for the development of aptamers market during the forecast period.

Recent developments in this industry:

  • In February 2019, the Base pair biotechnologies inc. has developed the point-of-care tests to diagnose neonatal abstinence syndrome based on aptamer with the assistance of the SBIR grant.
  • In January 2019, Aptamer Group announced that the AstraZeneca Company has agreed to collaborate with them for expanding the application potential of the aptamer technology. With this collaboration, AstraZeneca will adapt to the technology that is developed by the aptamer group to develop the advanced drug delivery vehicles which are named after Aptamer Drug Conjugates (ApDCs).

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Type, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, APAC, LATAM, Middle East and Africa

Companies Analysed

AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd, Aptus Biotech S.L, Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc., TriLink BioTechnologies Inc. and Vivonics, Inc.

 

This research report on the Global Aptamers Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Aptamers Market Analysis - By Type:

  • Peptide Aptamers
    • DNA-Based Aptamers
    • RNA-Based Aptamers
    • XNA-Based Aptamers
  • Nucleic Acid Aptamers

On the basis of type, DNA-based aptamers segment is dominating the global aptamer market with respect to product type and is accounted for contributing a major share of revenues to the market. This segment is likely to grow at an ample pace during the forecast period owing to increasing initiatives in research and developments on DNA-based aptamers.

Aptamers Market - By Application:

  • Therapeutics Development
  • Diagnostics
  • Research and Development

On the basis of application, the Diagnostic segment has contributed a significant share of revenues to the aptamers market in the recent past and is anticipated to be growing at a high pace due to a constantly increasing population with various diseases leading to a boost in demand for various diagnostic techniques.

Aptamers Market - By End User:

  • Pharmaceutical Companies
  • Bio-Pharmaceutical companies
  • Academic and Research Centres

On the basis of end-user, the academic and government research institutes market segment has contributed the major share to the market in recent years and is likely to grow further during the forecast period.

Regional Analysis:

North America dominates the global Aptamers market with the highest share followed by Europe, Asia - Pacific. Asia-Pacific is expected to account for the highest growth during the forecast period.

Companies leading the Global Aptamers Market profiled in the report are:

  1. AM Biotechnologies
  2. Aptagen
  3. Aptamer Sciences Inc.
  4. Aptamer Solutions Ltd
  5. Aptus Biotech S.L
  6. Base Pair Biotechnologies Inc.
  7. NeoVentures Biotechnology Inc.
  8. SomaLogic Inc.
  9. TriLink BioTechnologies Inc.
  10. Vivonics, Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Mexico     

                                6.4.4 Rest of Latin America         

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                        

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Aptamers Market By Region, From 2019-2024( USD Billion )
  2. Global Aptamers Market By Type, From 2019-2024( USD Billion )
  3. Global Peptide Aptamers Market By Region, From 2019-2024( USD Billion )
  4. Global Nucleic Acid Aptamers Market By Region, From 2019-2024( USD Billion )
  5. Global Aptamers Market By Application, From 2019-2024( USD Billion )
  6. Global Therapeutics Development Market By Region, From 2019-2024( USD Billion )
  7. Global Diagnostics Market By Region, From 2019-2024( USD Billion )
  8. Global Research and Development Market By Region, From 2019-2024( USD Billion )
  9. Global Aptamers Market By End users, From 2019-2024( USD Billion )
  10. Global Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  11. Global Bio-Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  12. Global Academic and Rsearch centers Market By Region, From 2019-2024( USD Billion )
  13. North America Aptamers Market By Type, From 2019-2024( USD Billion )
  14. North America Peptide Aptamers Market By Region, From 2019-2024( USD Billion )
  15. North America Nucleic Acid Aptamers Market By Region, From 2019-2024( USD Billion )
  16. North America Aptamers Market By Application, From 2019-2024( USD Billion )
  17. North America Therapeutics Development Market By Region, From 2019-2024( USD Billion )
  18. North America Diagnostics Market By Region, From 2019-2024( USD Billion )
  19. North America Research and Development Market By Region, From 2019-2024( USD Billion )
  20. North America Aptamers Market By End users, From 2019-2024( USD Billion )
  21. North America Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  22. North America Bio-Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  23. North America Academic and Rsearch centers Market By Region, From 2019-2024( USD Billion )
  24. United States Aptamers Market By Type, From 2019-2024( USD Billion )
  25. United States Aptamers Market By Application, From 2019-2024( USD Billion )
  26. United States Aptamers Market By End users, From 2019-2024( USD Billion )
  27. Canada Aptamers Market By Type, From 2019-2024( USD Billion )
  28. Canada Aptamers Market By Application, From 2019-2024( USD Billion )
  29. Canada Aptamers Market By End users, From 2019-2024( USD Billion )
  30. Europe Aptamers Market By Type, From 2019-2024( USD Billion )
  31. Europe Peptide Aptamers Market By Region, From 2019-2024( USD Billion )
  32. Europe Nucleic Acid Aptamers Market By Region, From 2019-2024( USD Billion )
  33. Europe Aptamers Market By Application, From 2019-2024( USD Billion )
  34. Europe Therapeutics Development Market By Region, From 2019-2024( USD Billion )
  35. Europe Diagnostics Market By Region, From 2019-2024( USD Billion )
  36. Europe Research and Development Market By Region, From 2019-2024( USD Billion )
  37. Europe Aptamers Market By End users, From 2019-2024( USD Billion )
  38. Europe Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  39. Europe Bio-Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  40. Europe Academic and Rsearch centers Market By Region, From 2019-2024( USD Billion )
  41. U.K. Aptamers Market By Type, From 2019-2024( USD Billion )
  42. U.K. Aptamers Market By Application, From 2019-2024( USD Billion )
  43. U.K. Aptamers Market By End users, From 2019-2024( USD Billion )
  44. Germany Aptamers Market By Type, From 2019-2024( USD Billion )
  45. Germany Aptamers Market By Application, From 2019-2024( USD Billion )
  46. Germany Aptamers Market By End users, From 2019-2024( USD Billion )
  47. France Aptamers Market By Type, From 2019-2024( USD Billion )
  48. France Aptamers Market By Application, From 2019-2024( USD Billion )
  49. France Aptamers Market By End users, From 2019-2024( USD Billion )
  50. Italy Aptamers Market By Type, From 2019-2024( USD Billion )
  51. Italy Aptamers Market By Application, From 2019-2024( USD Billion )
  52. Italy Aptamers Market By End users, From 2019-2024( USD Billion )
  53. Spain Aptamers Market By Type, From 2019-2024( USD Billion )
  54. Spain Aptamers Market By Application, From 2019-2024( USD Billion )
  55. Spain Aptamers Market By End users, From 2019-2024( USD Billion )
  56. Asia-Pacific Aptamers Market By Type, From 2019-2024( USD Billion )
  57. Asia-Pacific Peptide Aptamers Market By Region, From 2019-2024( USD Billion )
  58. Asia-Pacific Nucleic Acid Aptamers Market By Region, From 2019-2024( USD Billion )
  59. Asia-Pacific Aptamers Market By Application, From 2019-2024( USD Billion )
  60. Asia-Pacific Therapeutics Development Market By Region, From 2019-2024( USD Billion )
  61. Asia-Pacific Diagnostics Market By Region, From 2019-2024( USD Billion )
  62. Asia-Pacific Research and Development Market By Region, From 2019-2024( USD Billion )
  63. Asia-Pacific Aptamers Market By End users, From 2019-2024( USD Billion )
  64. Asia-Pacific Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  65. Asia-Pacific Bio-Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  66. Asia-Pacific Academic and Rsearch centers Market By Region, From 2019-2024( USD Billion )
  67. Japan Aptamers Market By Type, From 2019-2024( USD Billion )
  68. Japan Aptamers Market By Application, From 2019-2024( USD Billion )
  69. Japan Aptamers Market By End users, From 2019-2024( USD Billion )
  70. China Aptamers Market By Type, From 2019-2024( USD Billion )
  71. China Aptamers Market By Application, From 2019-2024( USD Billion )
  72. China Aptamers Market By End users, From 2019-2024( USD Billion )
  73. India Aptamers Market By Type, From 2019-2024( USD Billion )
  74. India Aptamers Market By Application, From 2019-2024( USD Billion )
  75. India Aptamers Market By End users, From 2019-2024( USD Billion )
  76. Australia Aptamers Market By Type, From 2019-2024( USD Billion )
  77. Australia Aptamers Market By Application, From 2019-2024( USD Billion )
  78. Australia Aptamers Market By End users, From 2019-2024( USD Billion )
  79. Latin America Aptamers Market By Type, From 2019-2024( USD Billion )
  80. Latin America Peptide Aptamers Market By Region, From 2019-2024( USD Billion )
  81. Latin America Nucleic Acid Aptamers Market By Region, From 2019-2024( USD Billion )
  82. Latin America Aptamers Market By Application, From 2019-2024( USD Billion )
  83. Latin America Therapeutics Development Market By Region, From 2019-2024( USD Billion )
  84. Latin America Diagnostics Market By Region, From 2019-2024( USD Billion )
  85. Latin America Research and Development Market By Region, From 2019-2024( USD Billion )
  86. Latin America Aptamers Market By End users, From 2019-2024( USD Billion )
  87. Latin America Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  88. Latin America Bio-Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  89. Latin America Academic and Rsearch centers Market By Region, From 2019-2024( USD Billion )
  90. Brazil Aptamers Market By Type, From 2019-2024( USD Billion )
  91. Brazil Aptamers Market By Application, From 2019-2024( USD Billion )
  92. Brazil Aptamers Market By End users, From 2019-2024( USD Billion )
  93. Rest of Latin America Aptamers Market By Type, From 2019-2024( USD Billion )
  94. Rest of Latin America Aptamers Market By Application, From 2019-2024( USD Billion )
  95. Rest of Latin America Aptamers Market By End users, From 2019-2024( USD Billion )
  96. Middle East & Africa Aptamers Market By Type, From 2019-2024( USD Billion )
  97. Middle East & Africa Peptide Aptamers Market By Region, From 2019-2024( USD Billion )
  98. Middle East & Africa Nucleic Acid Aptamers Market By Region, From 2019-2024( USD Billion )
  99. Middle East & Africa Aptamers Market By Application, From 2019-2024( USD Billion )
  100. Middle East & Africa Therapeutics Development Market By Region, From 2019-2024( USD Billion )
  101. Middle East & Africa Diagnostics Market By Region, From 2019-2024( USD Billion )
  102. Middle East & Africa Research and Development Market By Region, From 2019-2024( USD Billion )
  103. Middle East & Africa Aptamers Market By End users, From 2019-2024( USD Billion )
  104. Middle East & Africa Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  105. Middle East & Africa Bio-Pharmaceutical Companies Market By Region, From 2019-2024( USD Billion )
  106. Middle East & Africa Academic and Rsearch centers Market By Region, From 2019-2024( USD Billion )
  107. Middle East Aptamers Market By Type, From 2019-2024( USD Billion )
  108. Middle East Aptamers Market By Application, From 2019-2024( USD Billion )
  109. Middle East Aptamers Market By End users, From 2019-2024( USD Billion )
  110. Africa Aptamers Market By Type, From 2019-2024( USD Billion )
  111. Africa Aptamers Market By Application, From 2019-2024( USD Billion )
  112. Africa Aptamers Market By End users, From 2019-2024( USD Billion )
  113. Global Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  114. Global DNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  115. Global RNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  116. Global XNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  117. North America Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  118. North America DNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  119. North America RNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  120. North America XNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  121. United States Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  122. Canada Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  123. Europe Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  124. Europe DNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  125. Europe RNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  126. Europe XNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  127. U.K. Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  128. Germany Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  129. France Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  130. Italy Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  131. Spain Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  132. Asia-Pacific Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  133. Asia-Pacific DNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  134. Asia-Pacific RNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  135. Asia-Pacific XNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  136. Japan Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  137. China Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  138. India Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  139. Latin America Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  140. Latin America DNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  141. Latin America RNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  142. Latin America XNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  143. Brazil Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  144. Rest of Latin America Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  145. Middle East & Africa Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  146. Middle East & Africa DNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  147. Middle East & Africa RNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  148. Middle East & Africa XNA Based Aptamers Market By Region, From 2019-2024( USD Billion )
  149. Middle East Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )
  150. Africa Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample